avapritinib 50 MG Oral Tablet [Ayvakit]
- RxCUI
- 2559729
- RxNorm name
- avapritinib 50 MG Oral Tablet [Ayvakit]
- Display name
- avapritinib 50 MG Oral Tablet [Ayvakit]
- Full name
- avapritinib 50 MG Oral Tablet [Ayvakit]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ayvakit | AVAPRITINIB | Blueprint Medicines Corporation | 645c887c-8cd4-4623-8da9-ac223d71a8b9 | 2026-08-05 | Warnings, Adverse reactions | 2559729 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 645c887c-8cd4-4623-8da9-ac223d71a8b9 | avapritinib 50 MG Oral Tablet [Ayvakit] | SBD | 13 | These highlights do not include all the information needed to use AYVAKIT safely and effectively. See full prescribing information for AYVAKIT. AYVAKIT ® (avapritinib) tablets, for oral use Initial U.S. Approval: 2020 | 20250711 |
| 645c887c-8cd4-4623-8da9-ac223d71a8b9 | Ayvakit 50 MG Oral Tablet | SY | 13 | These highlights do not include all the information needed to use AYVAKIT safely and effectively. See full prescribing information for AYVAKIT. AYVAKIT ® (avapritinib) tablets, for oral use Initial U.S. Approval: 2020 | 20250711 |
| 645c887c-8cd4-4623-8da9-ac223d71a8b9 | AYVAKIT 50 MG Oral Tablet | PSN | 13 | These highlights do not include all the information needed to use AYVAKIT safely and effectively. See full prescribing information for AYVAKIT. AYVAKIT ® (avapritinib) tablets, for oral use Initial U.S. Approval: 2020 | 20250711 |